| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
222,941 |
204,104 |
$21.59M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
180,019 |
152,203 |
$17.31M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
42,611 |
12,771 |
$4.96M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
48,671 |
41,848 |
$4.58M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
69,201 |
20,685 |
$4.01M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
45,093 |
42,281 |
$3.92M |
| 80053 |
Comprehensive metabolic panel |
150,244 |
121,143 |
$3.29M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
35,202 |
28,220 |
$2.19M |
| 36415 |
Collection of venous blood by venipuncture |
157,171 |
125,046 |
$1.66M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
11,594 |
10,120 |
$1.62M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
34,526 |
10,640 |
$1.56M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
10,363 |
9,059 |
$1.18M |
| J9271 |
Injection, pembrolizumab, 1 mg |
613 |
394 |
$1.05M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
14,120 |
10,455 |
$1.02M |
| 59025 |
Fetal non-stress test |
25,524 |
20,707 |
$1.02M |
| 54161 |
|
1,190 |
1,148 |
$960K |
| 81003 |
|
87,827 |
76,735 |
$947K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
8,676 |
4,917 |
$872K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
11,679 |
10,131 |
$855K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
2,700 |
2,575 |
$855K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
16,844 |
14,648 |
$838K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
5,035 |
4,383 |
$823K |
| A0434 |
Specialty care transport (sct) |
6,641 |
3,933 |
$768K |
| 84703 |
|
47,446 |
41,167 |
$758K |
| 70450 |
Computed tomography, head or brain; without contrast material |
18,823 |
15,883 |
$742K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
6,016 |
5,173 |
$635K |
| G0378 |
Hospital observation service, per hour |
49,735 |
16,737 |
$633K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
6,913 |
6,324 |
$620K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
39,429 |
30,269 |
$602K |
| 93304 |
|
1,824 |
1,692 |
$586K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
37,844 |
28,649 |
$508K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
57,013 |
47,194 |
$502K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
43,279 |
32,161 |
$485K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
4,956 |
4,560 |
$485K |
| 71046 |
Radiologic examination, chest; 2 views |
26,925 |
24,419 |
$469K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
5,436 |
2,729 |
$468K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
944 |
862 |
$449K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
3,121 |
2,607 |
$439K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
24,113 |
22,598 |
$401K |
| 82962 |
|
28,065 |
17,089 |
$392K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
72,199 |
60,427 |
$385K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
6,238 |
5,980 |
$374K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
25,893 |
23,150 |
$373K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
17,656 |
13,350 |
$318K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
163,044 |
128,991 |
$309K |
| 95715 |
|
1,183 |
1,030 |
$288K |
| 77386 |
|
2,156 |
274 |
$284K |
| 77336 |
|
1,858 |
802 |
$282K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
4,104 |
3,786 |
$270K |
| 76770 |
|
3,042 |
2,941 |
$263K |
| 87631 |
|
18,988 |
17,612 |
$263K |
| 97161 |
|
2,767 |
2,463 |
$261K |
| 92567 |
|
6,915 |
6,540 |
$259K |
| 97162 |
|
3,706 |
3,290 |
$258K |
| 93308 |
|
1,279 |
1,122 |
$257K |
| 71045 |
Radiologic examination, chest; single view |
51,079 |
42,790 |
$251K |
| J2997 |
Injection, alteplase recombinant, 1 mg |
1,612 |
763 |
$248K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,337 |
2,122 |
$244K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
8,916 |
8,128 |
$238K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
9,384 |
8,100 |
$229K |
| 92587 |
|
5,627 |
5,298 |
$210K |
| 58661 |
|
175 |
140 |
$203K |
| 74019 |
|
8,499 |
8,063 |
$197K |
| 76775 |
|
3,154 |
2,988 |
$194K |
| 92523 |
|
1,872 |
1,795 |
$190K |
| 83986 |
|
2,208 |
1,944 |
$184K |
| 84702 |
|
11,342 |
7,915 |
$174K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
9,841 |
8,883 |
$173K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
56,319 |
52,840 |
$165K |
| 01999 |
|
9,644 |
8,966 |
$164K |
| 97597 |
|
3,323 |
1,964 |
$159K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,946 |
1,841 |
$157K |
| 36430 |
|
1,787 |
1,220 |
$156K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
14,151 |
11,492 |
$144K |
| 86850 |
|
16,592 |
14,245 |
$144K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
13,272 |
10,560 |
$143K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
4,296 |
3,960 |
$136K |
| 85027 |
|
43,169 |
34,633 |
$135K |
| 93017 |
|
4,536 |
3,878 |
$134K |
| 95812 |
|
594 |
568 |
$134K |
| 97163 |
|
1,394 |
1,232 |
$131K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
4,824 |
4,230 |
$130K |
| 81001 |
|
46,188 |
40,477 |
$124K |
| 97165 |
|
1,908 |
1,725 |
$120K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
7,019 |
6,438 |
$119K |
| 84484 |
|
46,468 |
34,265 |
$119K |
| 92526 |
|
3,956 |
1,185 |
$115K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
406 |
260 |
$114K |
| 70491 |
|
1,063 |
934 |
$111K |
| 97166 |
|
1,171 |
1,100 |
$110K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
802 |
705 |
$110K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
6,139 |
2,309 |
$106K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
414 |
365 |
$106K |
| 82330 |
|
3,949 |
3,042 |
$105K |
| 74018 |
|
5,446 |
4,379 |
$103K |
| 97010 |
|
2,560 |
997 |
$102K |
| 76801 |
|
7,048 |
5,614 |
$101K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
1,541 |
1,325 |
$100K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
485 |
424 |
$100K |
| 11045 |
|
640 |
327 |
$98K |
| 83735 |
|
37,770 |
27,242 |
$97K |
| G0379 |
Direct admission of patient for hospital observation care |
1,794 |
1,610 |
$97K |
| 97116 |
|
4,977 |
2,428 |
$96K |
| 73562 |
|
5,347 |
4,511 |
$90K |
| 93325 |
|
7,807 |
7,252 |
$89K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
373 |
341 |
$87K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
17,672 |
15,931 |
$86K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
1,757 |
1,329 |
$85K |
| 74230 |
|
1,086 |
945 |
$85K |
| 73630 |
|
4,642 |
4,092 |
$84K |
| 96367 |
|
2,482 |
1,757 |
$84K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
3,693 |
2,663 |
$83K |
| 74174 |
|
1,288 |
1,092 |
$81K |
| 76830 |
Ultrasound, transvaginal |
5,611 |
5,098 |
$80K |
| 73130 |
|
3,836 |
3,361 |
$78K |
| 86900 |
|
20,238 |
16,993 |
$78K |
| J9035 |
Injection, bevacizumab, 10 mg |
261 |
93 |
$77K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
9,243 |
3,142 |
$77K |
| 44970 |
|
56 |
55 |
$75K |
| 77300 |
|
233 |
167 |
$72K |
| 73610 |
|
4,279 |
3,805 |
$71K |
| 87486 |
|
4,316 |
3,975 |
$71K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
2,072 |
1,761 |
$67K |
| 97167 |
|
1,011 |
923 |
$65K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
6,208 |
5,020 |
$64K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
4,402 |
3,918 |
$64K |
| 93971 |
|
3,474 |
2,952 |
$63K |
| 95782 |
|
170 |
165 |
$62K |
| 85610 |
|
13,560 |
10,734 |
$61K |
| 73030 |
|
3,629 |
3,005 |
$60K |
| 82570 |
|
5,091 |
4,372 |
$60K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
579 |
563 |
$60K |
| 96401 |
|
839 |
436 |
$59K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
439 |
376 |
$57K |
| 77334 |
|
415 |
279 |
$57K |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
764 |
335 |
$57K |
| 87420 |
|
774 |
738 |
$56K |
| 93970 |
|
2,010 |
1,729 |
$55K |
| 76870 |
|
1,324 |
1,220 |
$54K |
| 84443 |
Thyroid stimulating hormone (TSH) |
22,583 |
19,603 |
$54K |
| 12011 |
|
1,706 |
1,570 |
$53K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,339 |
2,156 |
$53K |
| 70496 |
|
263 |
222 |
$53K |
| 77387 |
|
95 |
13 |
$52K |
| 87480 |
|
12,016 |
10,863 |
$52K |
| 74240 |
|
641 |
631 |
$52K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
2,094 |
1,808 |
$52K |
| 76536 |
|
988 |
915 |
$51K |
| 95700 |
|
1,181 |
1,128 |
$51K |
| 95819 |
|
795 |
733 |
$51K |
| 10060 |
|
1,114 |
1,010 |
$51K |
| C1769 |
Guide wire |
2,498 |
2,096 |
$51K |
| 92579 |
|
3,408 |
3,225 |
$50K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,149 |
878 |
$49K |
| 83690 |
|
28,254 |
24,270 |
$48K |
| 73110 |
|
2,886 |
2,498 |
$48K |
| 76885 |
|
539 |
527 |
$47K |
| 92557 |
|
708 |
666 |
$46K |
| 87070 |
|
3,416 |
3,005 |
$45K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
6,577 |
5,816 |
$45K |
| 87081 |
|
3,597 |
3,132 |
$44K |
| 73090 |
|
2,530 |
2,163 |
$42K |
| 82247 |
|
3,111 |
2,162 |
$42K |
| 12001 |
|
1,291 |
1,172 |
$42K |
| 96376 |
|
11,203 |
7,117 |
$41K |
| 20680 |
|
75 |
66 |
$40K |
| 73140 |
|
1,266 |
1,146 |
$40K |
| 36591 |
|
2,441 |
1,424 |
$39K |
| 87077 |
|
3,823 |
3,317 |
$38K |
| 16020 |
|
449 |
284 |
$38K |
| 82728 |
|
8,961 |
8,056 |
$38K |
| 73080 |
|
1,932 |
1,740 |
$37K |
| Q0114 |
Fern test |
2,401 |
2,101 |
$37K |
| 96402 |
|
300 |
217 |
$36K |
| 87634 |
|
1,030 |
984 |
$36K |
| 92610 |
|
610 |
535 |
$35K |
| 73590 |
|
2,770 |
2,354 |
$34K |
| 72141 |
|
645 |
594 |
$34K |
| 93356 |
|
561 |
529 |
$34K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
2,703 |
2,482 |
$34K |
| 74455 |
|
276 |
270 |
$33K |
| 82657 |
|
2,461 |
2,355 |
$33K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
17,606 |
15,872 |
$33K |
| 70486 |
|
1,940 |
1,673 |
$33K |
| 81025 |
|
23,020 |
20,838 |
$32K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
23,633 |
19,172 |
$31K |
| 83880 |
|
7,574 |
6,187 |
$30K |
| 80061 |
Lipid panel |
13,437 |
11,506 |
$30K |
| 99152 |
|
2,478 |
1,968 |
$30K |
| 87510 |
|
12,009 |
10,857 |
$30K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
7,681 |
7,143 |
$29K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
559 |
447 |
$29K |
| 76825 |
|
168 |
161 |
$28K |
| 86901 |
|
20,221 |
16,982 |
$28K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,417 |
1,353 |
$28K |
| 99153 |
Mod sedat endo service >5yrs |
2,229 |
1,809 |
$27K |
| 93296 |
|
2,201 |
1,833 |
$26K |
| 85730 |
|
8,239 |
7,008 |
$26K |
| 82565 |
|
3,186 |
2,669 |
$26K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
10,871 |
9,312 |
$26K |
| 96523 |
|
1,859 |
1,236 |
$25K |
| 93225 |
|
1,701 |
1,532 |
$25K |
| 01922 |
|
365 |
351 |
$25K |
| 87505 |
|
795 |
722 |
$24K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
71 |
68 |
$24K |
| 72100 |
|
2,327 |
2,020 |
$24K |
| 93280 |
|
1,675 |
1,360 |
$23K |
| 96415 |
|
1,166 |
663 |
$23K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
827 |
755 |
$22K |
| 86592 |
|
4,325 |
3,973 |
$22K |
| 92555 |
|
361 |
346 |
$21K |
| 85014 |
|
2,849 |
2,378 |
$21K |
| 87660 |
|
12,064 |
10,911 |
$21K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
13,329 |
12,206 |
$21K |
| 88307 |
|
847 |
764 |
$21K |
| 86140 |
|
8,753 |
7,468 |
$20K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,403 |
2,780 |
$20K |
| 90686 |
|
368 |
300 |
$20K |
| 70250 |
|
375 |
334 |
$19K |
| 71250 |
|
926 |
781 |
$19K |
| 86480 |
|
799 |
742 |
$19K |
| J0897 |
Injection, denosumab, 1 mg |
161 |
126 |
$19K |
| 93226 |
|
1,212 |
1,111 |
$18K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
3,513 |
2,856 |
$18K |
| L4350 |
Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf |
262 |
243 |
$18K |
| 12002 |
|
536 |
485 |
$18K |
| 84132 |
|
3,227 |
2,614 |
$18K |
| 95951 |
|
232 |
184 |
$18K |
| 72170 |
|
2,569 |
2,084 |
$18K |
| 73552 |
|
1,660 |
1,393 |
$18K |
| 72131 |
|
3,077 |
2,524 |
$17K |
| 87040 |
|
5,557 |
4,753 |
$17K |
| 92552 |
|
336 |
315 |
$17K |
| V5011 |
Fitting/orientation/checking of hearing aid |
504 |
443 |
$17K |
| 83550 |
|
7,015 |
6,405 |
$17K |
| 92652 |
|
350 |
325 |
$17K |
| 88304 |
|
1,286 |
1,196 |
$17K |
| 73502 |
|
1,449 |
1,258 |
$17K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
75 |
63 |
$16K |
| 72040 |
|
892 |
778 |
$16K |
| 82550 |
|
4,475 |
3,766 |
$16K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,554 |
1,287 |
$16K |
| 85379 |
|
6,386 |
5,646 |
$16K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
3,045 |
2,853 |
$16K |
| 93880 |
|
826 |
674 |
$16K |
| 83605 |
|
7,006 |
5,803 |
$15K |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
937 |
780 |
$15K |
| 97542 |
|
197 |
163 |
$15K |
| 96409 |
|
1,428 |
833 |
$15K |
| 82378 |
|
1,929 |
1,325 |
$14K |
| 76010 |
|
339 |
316 |
$14K |
| 96368 |
|
523 |
341 |
$14K |
| 70360 |
|
544 |
521 |
$14K |
| 92585 |
|
338 |
297 |
$14K |
| J1756 |
Injection, iron sucrose, 1 mg |
1,042 |
468 |
$13K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
12,335 |
10,002 |
$13K |
| 82784 |
|
1,929 |
1,719 |
$13K |
| 73060 |
|
1,070 |
900 |
$13K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
8,144 |
7,230 |
$13K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
9,379 |
7,845 |
$13K |
| 10061 |
|
285 |
254 |
$12K |
| 93798 |
|
232 |
38 |
$12K |
| 93282 |
|
585 |
513 |
$11K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
2,930 |
899 |
$11K |
| 70543 |
|
149 |
143 |
$11K |
| 76641 |
|
239 |
199 |
$11K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,608 |
3,424 |
$11K |
| 84439 |
|
7,800 |
7,073 |
$11K |
| 24640 |
|
39 |
38 |
$11K |
| 80074 |
|
1,032 |
891 |
$11K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,950 |
1,071 |
$10K |
| J1453 |
Injection, fosaprepitant, 1 mg |
350 |
215 |
$10K |
| 86308 |
|
1,688 |
1,563 |
$10K |
| 87507 |
|
309 |
290 |
$10K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14,791 |
13,107 |
$10K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
4,112 |
3,205 |
$10K |
| 72197 |
|
61 |
54 |
$10K |
| 87529 |
|
781 |
720 |
$10K |
| 51600 |
|
273 |
265 |
$10K |
| A6454 |
Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to three inches and less than five inches, per yard |
94 |
27 |
$10K |
| 96450 |
|
46 |
38 |
$10K |
| 72128 |
|
2,227 |
1,792 |
$10K |
| 85018 |
|
3,607 |
3,021 |
$9K |
| 93299 |
|
418 |
360 |
$9K |
| 87186 |
|
7,337 |
6,407 |
$9K |
| 82024 |
|
595 |
472 |
$9K |
| 83540 |
|
7,536 |
6,864 |
$9K |
| 86923 |
|
804 |
592 |
$9K |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
36 |
33 |
$9K |
| J2790 |
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
710 |
663 |
$9K |
| 70498 |
|
252 |
224 |
$9K |
| 93886 |
|
100 |
94 |
$9K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
78 |
67 |
$9K |
| 77301 |
|
44 |
26 |
$8K |
| 84100 |
|
9,680 |
6,715 |
$8K |
| 93321 |
|
2,970 |
2,692 |
$8K |
| J2800 |
Injection, methocarbamol, up to 10 ml |
3,189 |
2,639 |
$8K |
| 83020 |
|
3,355 |
2,617 |
$8K |
| A6261 |
Wound filler, gel/paste, per fluid ounce, not otherwise specified |
285 |
137 |
$8K |
| 85652 |
|
8,180 |
6,988 |
$8K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
348 |
300 |
$7K |
| 84145 |
|
1,800 |
1,608 |
$7K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
37 |
36 |
$7K |
| A6198 |
Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 48 sq. in., each dressing |
156 |
92 |
$7K |
| 86922 |
|
464 |
359 |
$7K |
| 93298 |
|
842 |
736 |
$7K |
| 77412 |
|
63 |
12 |
$7K |
| 90715 |
|
2,368 |
2,014 |
$7K |
| 83970 |
|
1,794 |
1,535 |
$7K |
| J2505 |
Injection, pegfilgrastim, 6 mg |
17 |
12 |
$7K |
| 87210 |
|
2,178 |
1,991 |
$7K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
3,885 |
1,481 |
$6K |
| 87340 |
|
4,084 |
3,675 |
$6K |
| 86003 |
|
964 |
870 |
$6K |
| 88185 |
|
139 |
123 |
$6K |
| 86902 |
|
1,009 |
831 |
$6K |
| 70544 |
|
246 |
221 |
$6K |
| 36592 |
|
712 |
535 |
$6K |
| 86870 |
|
447 |
384 |
$6K |
| 84295 |
|
1,551 |
1,324 |
$6K |
| V5264 |
Ear mold/insert, not disposable, any type |
99 |
84 |
$6K |
| 86300 |
|
837 |
615 |
$6K |
| 82805 |
|
2,093 |
1,827 |
$6K |
| 82248 |
|
5,556 |
4,261 |
$6K |
| 85244 |
|
223 |
212 |
$6K |
| 96417 |
|
1,320 |
814 |
$5K |
| 00300 |
|
127 |
124 |
$5K |
| 78451 |
|
45 |
37 |
$5K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
380 |
318 |
$5K |
| 00210 |
|
71 |
71 |
$5K |
| 84520 |
|
1,428 |
1,199 |
$5K |
| 29581 |
|
120 |
51 |
$5K |
| 82607 |
|
4,118 |
3,603 |
$5K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
392 |
329 |
$5K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
190 |
165 |
$5K |
| J2704 |
Injection, propofol, 10 mg |
10,766 |
8,856 |
$5K |
| 87581 |
|
4,312 |
3,972 |
$5K |
| 82150 |
|
1,001 |
829 |
$5K |
| 87641 |
|
383 |
332 |
$5K |
| 85045 |
|
10,573 |
8,674 |
$5K |
| 82947 |
|
1,494 |
1,316 |
$4K |
| 29125 |
|
712 |
648 |
$4K |
| 43762 |
|
47 |
41 |
$4K |
| J9045 |
Injection, carboplatin, 50 mg |
165 |
93 |
$4K |
| 73660 |
|
187 |
172 |
$4K |
| 92586 |
|
51 |
44 |
$4K |
| 86787 |
|
783 |
742 |
$4K |
| 74021 |
|
328 |
287 |
$4K |
| A6197 |
Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing |
254 |
176 |
$4K |
| 85245 |
|
293 |
281 |
$4K |
| 83520 |
|
705 |
676 |
$4K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,947 |
1,444 |
$4K |
| 87205 |
|
2,814 |
2,476 |
$4K |
| 82435 |
|
1,239 |
1,077 |
$4K |
| 85384 |
|
2,269 |
2,022 |
$4K |
| 94060 |
|
36 |
36 |
$4K |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
87 |
25 |
$4K |
| 82785 |
|
1,002 |
962 |
$3K |
| J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg |
17 |
13 |
$3K |
| 87147 |
|
1,760 |
1,564 |
$3K |
| 36410 |
|
229 |
175 |
$3K |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,554 |
966 |
$3K |
| 88342 |
|
1,132 |
979 |
$3K |
| 73000 |
|
68 |
66 |
$3K |
| 36593 |
|
98 |
74 |
$3K |
| 82803 |
|
257 |
225 |
$3K |
| 73560 |
|
387 |
283 |
$3K |
| 73521 |
|
68 |
67 |
$3K |
| 76818 |
|
60 |
55 |
$3K |
| 76377 |
|
292 |
252 |
$3K |
| 93270 |
|
64 |
49 |
$3K |
| 59320 |
|
13 |
13 |
$3K |
| 93283 |
|
158 |
137 |
$3K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,503 |
1,308 |
$2K |
| 83021 |
|
3,351 |
2,619 |
$2K |
| 00920 |
|
876 |
841 |
$2K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
3,029 |
1,951 |
$2K |
| 83615 |
|
3,767 |
3,321 |
$2K |
| 82746 |
|
2,654 |
2,269 |
$2K |
| 72158 |
|
100 |
92 |
$2K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
433 |
395 |
$2K |
| 93284 |
|
203 |
178 |
$2K |
| 86360 |
|
690 |
578 |
$2K |
| 71101 |
|
150 |
135 |
$2K |
| 86920 |
|
1,489 |
1,205 |
$2K |
| 87497 |
|
125 |
82 |
$2K |
| 72156 |
|
65 |
63 |
$2K |
| 72146 |
|
304 |
294 |
$2K |
| 97535 |
Self-care/home management training, each 15 minutes |
577 |
340 |
$2K |
| 92556 |
|
188 |
176 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
9,095 |
6,814 |
$2K |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
168 |
125 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,256 |
1,062 |
$2K |
| A0425 |
Ground mileage, per statute mile |
1,310 |
1,041 |
$2K |
| 80197 |
|
1,636 |
1,008 |
$2K |
| 85246 |
|
557 |
519 |
$2K |
| 76000 |
|
75 |
67 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
5,909 |
4,800 |
$2K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,940 |
1,741 |
$2K |
| 84157 |
|
608 |
516 |
$2K |
| 77072 |
|
47 |
46 |
$2K |
| 86706 |
|
1,012 |
951 |
$2K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
333 |
320 |
$2K |
| 76800 |
|
20 |
18 |
$2K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
531 |
348 |
$2K |
| 75571 |
|
104 |
86 |
$2K |
| 99151 |
|
281 |
228 |
$2K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
517 |
501 |
$2K |
| 00500 |
|
79 |
68 |
$2K |
| 82575 |
|
156 |
144 |
$2K |
| 82670 |
|
178 |
173 |
$2K |
| 69200 |
|
33 |
28 |
$2K |
| 92611 |
|
850 |
755 |
$2K |
| 99219 |
|
1,025 |
813 |
$1K |
| 00731 |
|
331 |
314 |
$1K |
| 85240 |
|
401 |
364 |
$1K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
103 |
75 |
$1K |
| 85660 |
|
4,038 |
2,850 |
$1K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
649 |
599 |
$1K |
| 36000 |
|
123 |
96 |
$1K |
| 86038 |
|
669 |
613 |
$1K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
112 |
100 |
$1K |
| 87075 |
|
743 |
621 |
$1K |
| 90378 |
|
43 |
35 |
$1K |
| 99218 |
|
488 |
350 |
$1K |
| 87015 |
|
41 |
37 |
$1K |
| J2785 |
Injection, regadenoson, 0.1 mg |
868 |
705 |
$1K |
| 86803 |
|
1,984 |
1,876 |
$1K |
| 97032 |
|
64 |
37 |
$1K |
| C1726 |
Catheter, balloon dilatation, non-vascular |
162 |
143 |
$1K |
| 82140 |
|
417 |
333 |
$1K |
| 92582 |
|
146 |
131 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13,861 |
11,961 |
$1K |
| 83655 |
|
304 |
293 |
$1K |
| 96040 |
|
14 |
13 |
$1K |
| 00320 |
|
217 |
198 |
$1K |
| OP259 |
|
130 |
92 |
$1K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
134 |
101 |
$1K |
| 84156 |
|
5,237 |
4,216 |
$1K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
396 |
226 |
$1K |
| G8997 |
Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
95 |
75 |
$1K |
| G8996 |
Swallowing functional limitation, current status at therapy episode outset and at reporting intervals |
95 |
75 |
$1K |
| 82272 |
|
25 |
24 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
44 |
37 |
$1K |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,118 |
692 |
$1K |
| 72070 |
|
71 |
58 |
$1K |
| 80164 |
|
257 |
220 |
$1K |
| 96411 |
|
704 |
452 |
$1K |
| 86762 |
|
2,200 |
2,066 |
$1K |
| 76642 |
|
80 |
65 |
$983.06 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
2,237 |
1,792 |
$980.91 |
| 80076 |
|
267 |
239 |
$913.75 |
| 87176 |
|
2,371 |
2,276 |
$899.73 |
| 93320 |
|
2,507 |
2,376 |
$897.27 |
| 77066 |
Tomosynthesis, mammo |
28 |
25 |
$874.69 |
| 87799 |
|
182 |
127 |
$873.20 |
| 82950 |
|
447 |
426 |
$868.45 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
60 |
52 |
$850.33 |
| 86364 |
|
185 |
170 |
$834.54 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
279 |
172 |
$832.61 |
| 77338 |
|
47 |
29 |
$809.14 |
| 86359 |
|
693 |
580 |
$793.78 |
| 84550 |
|
1,325 |
1,150 |
$772.82 |
| 87449 |
|
145 |
123 |
$758.73 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
403 |
348 |
$730.23 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
282 |
249 |
$709.21 |
| J9370 |
Vincristine sulfate, 1 mg |
388 |
240 |
$696.88 |
| 87536 |
|
56 |
48 |
$688.67 |
| 51701 |
|
1,178 |
1,085 |
$673.13 |
| 01462 |
|
125 |
120 |
$659.25 |
| 76376 |
|
15 |
14 |
$657.38 |
| 84146 |
|
278 |
251 |
$651.53 |
| 83001 |
|
457 |
433 |
$648.14 |
| 84403 |
|
538 |
484 |
$644.90 |
| 12013 |
|
32 |
26 |
$595.89 |
| 84311 |
|
2,533 |
2,427 |
$588.80 |
| 76827 |
|
207 |
197 |
$578.36 |
| 00790 |
|
24 |
22 |
$573.89 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,254 |
1,006 |
$570.42 |
| 85576 |
|
254 |
226 |
$558.40 |
| 01965 |
|
42 |
40 |
$551.90 |
| G8990 |
Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals |
37 |
24 |
$547.36 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
666 |
572 |
$539.83 |
| A0390 |
Als mileage (per mile) |
4,598 |
2,346 |
$527.42 |
| J1815 |
Injection, insulin, per 5 units |
395 |
294 |
$512.55 |
| 83516 |
|
444 |
431 |
$510.65 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
372 |
288 |
$504.37 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
36 |
27 |
$500.77 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
36 |
27 |
$500.77 |
| 0450 |
Emergency room services |
14 |
13 |
$480.98 |
| 73600 |
|
32 |
27 |
$476.10 |
| 00630 |
|
12 |
12 |
$472.02 |
| 72157 |
|
39 |
38 |
$463.90 |
| 72050 |
|
13 |
13 |
$460.42 |
| 90714 |
|
534 |
445 |
$455.60 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
561 |
455 |
$455.09 |
| 49465 |
|
168 |
140 |
$454.31 |
| 88313 |
|
136 |
121 |
$453.30 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
319 |
263 |
$453.25 |
| 86769 |
|
158 |
143 |
$451.66 |
| 00520 |
|
13 |
13 |
$430.57 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,501 |
2,468 |
$412.63 |
| 97760 |
|
14 |
12 |
$408.67 |
| 77080 |
|
22 |
12 |
$400.95 |
| J9190 |
Injection, fluorouracil, 500 mg |
37 |
12 |
$391.38 |
| 82043 |
|
815 |
692 |
$374.81 |
| 83525 |
|
371 |
360 |
$354.78 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
251 |
226 |
$333.69 |
| 95709 |
|
16 |
16 |
$328.73 |
| 94644 |
|
82 |
77 |
$324.02 |
| 81479 |
Unlisted molecular pathology procedure |
12 |
12 |
$303.84 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
518 |
424 |
$302.59 |
| 86880 |
|
708 |
599 |
$300.02 |
| 93285 |
|
30 |
25 |
$296.46 |
| 88341 |
|
155 |
133 |
$287.37 |
| G8998 |
Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting |
36 |
27 |
$281.29 |
| 72072 |
|
12 |
12 |
$278.50 |
| 88184 |
|
141 |
125 |
$278.16 |
| J9260 |
Injection, methotrexate sodium, 50 mg |
223 |
162 |
$258.99 |
| 84481 |
|
273 |
247 |
$253.80 |
| 89050 |
|
292 |
250 |
$242.49 |
| OP251 |
|
21 |
15 |
$235.51 |
| 86355 |
|
84 |
70 |
$228.88 |
| 84460 |
|
304 |
262 |
$224.09 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
2,386 |
1,255 |
$218.52 |
| 86665 |
|
25 |
25 |
$218.48 |
| 82379 |
|
465 |
452 |
$213.93 |
| 87071 |
|
291 |
268 |
$203.24 |
| 80050 |
General health panel |
66 |
61 |
$200.21 |
| 86905 |
|
20 |
17 |
$185.01 |
| 82105 |
|
203 |
167 |
$184.77 |
| 82533 |
|
130 |
110 |
$177.86 |
| 95886 |
|
58 |
39 |
$176.39 |
| 86376 |
|
645 |
575 |
$175.93 |
| J2060 |
Injection, lorazepam, 2 mg |
1,207 |
984 |
$175.70 |
| 82010 |
|
530 |
473 |
$174.16 |
| 86235 |
|
16 |
14 |
$147.86 |
| 88360 |
|
57 |
53 |
$133.56 |
| J3480 |
Injection, potassium chloride, per 2 meq |
199 |
149 |
$129.99 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
134 |
65 |
$123.20 |
| 86160 |
|
32 |
28 |
$122.81 |
| 76942 |
|
16 |
14 |
$119.24 |
| 86304 |
|
57 |
41 |
$118.65 |
| 82977 |
|
884 |
788 |
$116.47 |
| 84436 |
|
78 |
68 |
$113.50 |
| 86357 |
|
84 |
70 |
$109.96 |
| 86147 |
|
12 |
12 |
$104.08 |
| 88142 |
|
12 |
12 |
$92.72 |
| 82951 |
|
12 |
12 |
$92.16 |
| 86800 |
|
184 |
166 |
$88.45 |
| 82945 |
|
348 |
300 |
$78.10 |
| J1630 |
Injection, haloperidol, up to 5 mg |
281 |
239 |
$69.25 |
| J1953 |
Injection, levetiracetam, 10 mg |
530 |
395 |
$69.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,106 |
965 |
$66.67 |
| 87324 |
|
73 |
69 |
$64.23 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
30 |
25 |
$62.74 |
| 85230 |
|
32 |
29 |
$61.03 |
| 86301 |
|
18 |
12 |
$56.34 |
| 89230 |
|
21 |
14 |
$55.08 |
| 0279U |
|
13 |
12 |
$49.78 |
| J1790 |
Injection, droperidol, up to 5 mg |
68 |
65 |
$48.96 |
| 96167 |
|
43 |
38 |
$48.70 |
| 73070 |
|
14 |
13 |
$41.18 |
| 84480 |
|
291 |
265 |
$39.89 |
| 85397 |
|
41 |
39 |
$39.84 |
| 87102 |
|
225 |
195 |
$39.12 |
| 84450 |
|
134 |
121 |
$38.34 |
| 87181 |
|
66 |
55 |
$34.80 |
| 82438 |
|
69 |
57 |
$29.69 |
| 84305 |
|
83 |
80 |
$28.85 |
| 94729 |
|
52 |
50 |
$26.98 |
| 86765 |
|
565 |
538 |
$26.02 |
| 87073 |
|
276 |
253 |
$25.34 |
| 85670 |
|
26 |
25 |
$24.72 |
| A6210 |
Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing |
30 |
14 |
$23.54 |
| 87653 |
|
17 |
12 |
$21.02 |
| 85130 |
|
75 |
69 |
$20.24 |
| 83883 |
|
16 |
14 |
$19.83 |
| 83002 |
|
357 |
339 |
$19.62 |
| 86735 |
|
567 |
541 |
$18.92 |
| 87116 |
|
78 |
68 |
$17.54 |
| 84630 |
|
71 |
69 |
$11.76 |
| 88108 |
|
141 |
114 |
$8.12 |
| 84165 |
|
29 |
24 |
$6.68 |
| 84478 |
|
185 |
108 |
$6.10 |
| 84133 |
|
12 |
12 |
$4.69 |
| 01990 |
|
67 |
66 |
$4.06 |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
56 |
55 |
$4.06 |
| 29505 |
|
15 |
14 |
$3.87 |
| 87206 |
|
75 |
65 |
$3.87 |
| 86431 |
|
46 |
43 |
$3.36 |
| 86225 |
|
30 |
26 |
$3.36 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
770 |
568 |
$3.26 |
| 73100 |
|
13 |
13 |
$2.79 |
| J7510 |
Prednisolone oral, per 5 mg |
750 |
673 |
$1.50 |
| 84155 |
|
51 |
40 |
$1.48 |
| 29515 |
|
90 |
84 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
452 |
438 |
$0.00 |
| 01820 |
|
99 |
91 |
$0.00 |
| 00940 |
|
319 |
290 |
$0.00 |
| 89051 |
|
15 |
12 |
$0.00 |
| 00840 |
|
63 |
55 |
$0.00 |
| 76937 |
|
49 |
43 |
$0.00 |
| J3486 |
Injection, ziprasidone mesylate, 10 mg |
233 |
170 |
$0.00 |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
13 |
13 |
$0.00 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
69 |
37 |
$0.00 |
| 82652 |
|
16 |
15 |
$0.00 |
| 86663 |
|
26 |
26 |
$0.00 |
| 84112 |
|
17 |
16 |
$0.00 |
| 88302 |
|
74 |
53 |
$0.00 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
79 |
69 |
$0.00 |
| 58670 |
|
19 |
13 |
$0.00 |
| 00750 |
|
31 |
29 |
$0.00 |
| 85347 |
|
58 |
50 |
$0.00 |
| 97803 |
|
26 |
15 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
14 |
12 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
16 |
14 |
$0.00 |
| 90461 |
|
13 |
13 |
$0.00 |
| 86664 |
|
25 |
25 |
$0.00 |
| 51798 |
|
57 |
44 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,438 |
1,252 |
$0.00 |
| J0610 |
Injection, calcium gluconate (fresenius kabi), per 10 ml |
30 |
26 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
142 |
84 |
$0.00 |
| 74183 |
|
13 |
13 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
13 |
12 |
$0.00 |
| 97802 |
|
26 |
26 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
218 |
81 |
$0.00 |
| 84255 |
|
33 |
32 |
$0.00 |
| 84160 |
|
18 |
12 |
$0.00 |
| 80177 |
|
16 |
13 |
$0.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
292 |
265 |
$0.00 |
| 84402 |
|
25 |
24 |
$0.00 |
| 82525 |
|
32 |
31 |
$0.00 |
| 84075 |
|
13 |
13 |
$0.00 |
| J9202 |
Goserelin acetate implant, per 3.6 mg |
36 |
24 |
$0.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
124 |
98 |
$0.00 |
| 01710 |
|
35 |
32 |
$0.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
33 |
32 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
101 |
87 |
$0.00 |
| 92650 |
|
25 |
21 |
$0.00 |
| 84485 |
|
16 |
12 |
$0.00 |
| 88311 |
|
12 |
12 |
$0.00 |
| 81050 |
|
36 |
30 |
$0.00 |
| 82139 |
|
13 |
12 |
$0.00 |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
25 |
13 |
$0.00 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
17 |
12 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
28 |
26 |
$0.00 |
| 94660 |
|
14 |
12 |
$0.00 |
| 82952 |
|
12 |
12 |
$0.00 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
30 |
25 |
$0.00 |
| G8991 |
Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
40 |
25 |
$0.00 |
| J3411 |
Injection, thiamine hcl, 100 mg |
17 |
13 |
$0.00 |
| 84153 |
|
15 |
13 |
$0.00 |
| A4648 |
Tissue marker, implantable, any type, each |
34 |
24 |
$0.00 |
| 00930 |
|
26 |
26 |
$0.00 |
| 82040 |
|
13 |
13 |
$0.00 |
| 73620 |
|
14 |
13 |
$0.00 |
| C9250 |
Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml |
16 |
12 |
$0.00 |